← All trials
NCT06056323
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 18, 2023
- Primary completion
- Sep 19, 2025
- Completion date
- Mar 19, 2026
- First posted
- Sep 28, 2023
- Last posted
- Oct 23, 2023
- Enrollment
- 71
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zhejiang Huahai Pharmaceutical Co., Ltd.Lead sponsor
- Harvard UniversityCollaborator
- University of Texas at HoustonCollaborator
- Gabrail Cancer CenterCollaborator
- Zhejiang Huahai Pharmaceutical Co., Ltd.Study chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.